Trials / Completed
CompletedNCT03005353
Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.
Randomized Clinical Trial for Treatment of Candidal Vulvovaginitis Using Cumin Seed Extract Vaginal Suppositories.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
Fungal infections have increased over the last two decades, largely because of the increasing size of the population at risk, including patients who are immunocompromised, broad-spectrum antibiotics and intravascular catheter users. Essential oils and other extracts of plants have evoked interest as sources of natural products. They have been shown to possess antibacterial, antifungal, antiviral, insecticidal and antioxidant properties. To the best of our knowledge, no study has examined the efficacy of cumin seed extract on relieving vulvovaginal candidiasis in vivo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cumin seed extract | patients will receive the drug in suppository form |
| DRUG | clotrimazole | patients will receive the drug in suppository form |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-10-31
- Completion
- 2020-01-31
- First posted
- 2016-12-29
- Last updated
- 2020-06-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03005353. Inclusion in this directory is not an endorsement.